Campylobacter jejuni infection is an important trigger of Guillain-Barré syndrome (GBS), and serotype HS:19 strains are over-represented among GBS-associated isolates. Structures in C. jejuni lipooligosaccharide (LOS) resemble human gangliosides, suggesting that molecular mimicry could be important in triggering the neural injury. We assessed the genetic diversity among 36 C. jejuni serotype HS:19 and non-HS:19 strains by analysis of PCR-based restriction fragment length polymorphism (RFLP) patterns of 12 LOS biosynthesis-related genes (wla cluster). PCR amplification revealed that the size, order, and direction of each wla gene was identical among all strains tested. However, an additional ORF, located between wlaI and wlaK, was detected in 28 of the 36 isolates examined, and nucleotide sequence analysis revealed that the gene was identical to orfE in C. jejuni strain NCTC 11168. An inverted repeat motif was found downstream of the wlaI stop codon and upstream of the orfE stop codon, an organization allowing pairing of repeated sequences that could lead to deletion of the internal segment. Digestion of the PCR products with restriction endonuclease DdeI or AluI and cluster analysis of RFLP banding patterns showed that all HS:19 strains were closely related and distinct from non-HS:19 strains, consistent with earlier analyses, suggesting that HS:19 strains represent a highly clonal population. RFLP analysis of wla genes also may be useful for epidemiological studies.
References
1.
Blaser MJ, Berkowitz ID, LaForce FM, Cravens J., Reller LB, Wang WICampylobacter enteritis: clinical and epidemiological features. Ann Intern Med1979; 91: 179—185.
2.
Allos BM, Blaser MJPotential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. J Endotoxin Res1995; 2: 237—238.
3.
Skirrow MB, Blaser MJClinical aspects of Campylobacter infection. In: Nachamkin I, Blaser MJ. (eds) Campylobacter. Washington DC: ASM Press, 2000; 69—88.
4.
Patton CM, Wachsmuth IKTyping schemes: are current methods useful? In: Nachamkin I, Blaser MJ, Tompkins LS. (eds) Campylobacter jejuni: Current Status and Future Trends. Washington, DC: American Society for Microbiology, 1992; 110—128.
5.
Penner JL, Hennessy JN, Congi RVSerotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur J Clin Microbiol1983; 2: 378—383.
6.
Aspinall GO, McDonald AG, Raju TS, Pang H., Moran HP, Penner JLChemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O23 and O:36 lipopolysaccharides. Eur J Biochem1993; 213: 1017—1027.
7.
Penner JLThe genus Campylobacter: a decade of progress. Clin Microbiol Rev1988; 1: 157—172.
8.
Preston MA, Penner JLStructural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni. Infect Immun1987; 55: 1806—1812.
9.
Karlyshev AV , Linton D., Gregson NA, Lastovica AJ, Wren BWGenetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity . Mol Microbiol2000; 35: 529—541.
10.
Chart H., Frost JA, Oza A., Thwaites R., Gillanders S., Rowe B.Heat-stable serotyping antigens expressed by strains of Campylobacter jejuni are probably capsular and not long-chain lipopolysaccharide. J Appl Bacteriol1996; 81: 635—640.
11.
Moran AP, Penner JLSerotyping of Campylobacter jejuni based on heat-stable antigens: relevance, molecular basis and implications in pathogenesis. J Appl Microbiol1999; 86: 361—377.
12.
Aspinall GO , Fujimoto S., McDonald AG, Pang H., Kurjanczyk LA, Penner JLLipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome mimic human gangliosides in structure . Infect Immun1994; 62: 2122—2125.
13.
Moran AP, O'Malley DT. Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. J Endotoxin Res1995; 2: 233—235.
14.
Yuki N., Handa S., Taki T. et al. Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between ganglioside GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed Res1992; 13: 451—453.
15.
Yuki N., Taki T., Inagaki F. et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med1993; 178: 1771—1775.
Hughes Rac, Rees JHClinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis1997; 176 (Suppl2): S92—S98.
18.
Nachamkin I. , Allos BM, Ho T.Campylobacter jejuni infection and the Guillain-Barré syndrome. Clin Microbiol Rev1998; 11: 555—567.
19.
Fujimoto S. , Yuki N., Itoh T., Amako K.Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome. J Infect Dis1992; 165: 183.
20.
Kuroki S., Saida T., Nukina M. et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann Neurol1993; 33: 243—247.
21.
Fujimoto S. , Allos BM, Misawa N., Patton CM, Blaser MJRestriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome. J Infect Dis1997; 176: 1105—1108.
22.
Misawa N., Allos BM, Blaser MJDifferentiation of Campylobacter jejuni strains of serotype O19 from non-O19 strains by polymerase chain reaction. J Clin Microbiol1998; 36: 3567—3573.
23.
Tsang Rsw, Frosk P., Johnsos WMHeat-labile serotyping of two Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome and belonging to serotype O19 (Penner). J Clin Microbiol2000; 38: 2021—2022.
24.
Aspinall GO , McDonald AG, Pang H., Kurjanczyk LA, Penner LJLipopolysaccharides of Campylobacter jejuni serotype O: 19: structures of the core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome . Biochemistry1994; 33: 241—249.
25.
Yuki N., Sato S., Fujimoto S. et al. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome. Muscle Nerve1992; 15: 968—969.
26.
Fry BN, Korolik V., ten Brinke JA et al. The lipopolysaccharide biosynthesis locus of Campylobacter jejuni 81116. Microbiology1998; 144: 2049—2061.
27.
Sacks JJ, Lieb S., Baldy LM et al. Epidemic campylobacteriosis associated with a community water supply. Am J Public Health1986; 76: 424—428.
28.
Yuki N., Handa S., Tai T. et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome . J Neurol Sci1995; 130: 112—116
29.
Penner JL, Hennessy JNPassive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol1980; 12: 732—737.
30.
Lior H., Woodward DL, Edgar JA, Laroche LJ, Gill P.Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J Clin Microbiol1982; 15: 761—768.
31.
Wilson K.Preparation of genomic DNA from bacteria. In: Ausubel FM et al. (eds) Current Protocols in Molecular Biology , vol. 1. New York: John Wiley, 1987; Unit 2.4.
32.
Sneath PH, Sokal RRNumerical Taxonomy, the Principles and Practice of Numerical Classification . San Francisco, CA: WH Freeman , 1973.
33.
Wood AC, Oldfield NJ, O'Dwyer CA, Ketley JMCloning, mutation and distribution of a putative lipopolysaccharide biosynthesis locus in Campylobacter jejuni. Microbiology1999; 145: 379—388.
34.
Parkhill J. , Wren BW, Mungall K. et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature2000; 403: 665—668.
35.
Wassenaar TM , Newell DGGenotyping of Campylobacter spp. Appl Environ Microbiol1999; 66: 1—9.
36.
Mazurier S. , van de Giessen A., Heuvelman K., Wernars K.RAPD analysis of Campylobacter isolates: DNA fingerprinting without the need to purify DNA. Lett Appl Microbiol1992; 14: 260—262.
37.
Lorenz E., Lastovica A., Owen RJSubtyping of Campylobacter jejuni Penner serotypes 9, 38 and 63 from human infections, animals and water by pulsed field gel electrophoresis and flagellin gene analysis. Lett Appl Microbiol1998; 26: 179—182.
38.
Patton CM, Wachsmuth IK, Evins GM et al. Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J Clin Microbiol1991 ; 29: 680—688.
39.
Duim B., Wassenaar TM, Rigter A., Wagenaar J.High-resolution genotyping of Campylobacter strains isolated from poultry and humans with amplified fragment length polymorphism fingerprinting. Appl Environ Microbiol1999; 65: 2369—2375.
40.
Nachamkin I., Bohachick K., Patton CMFlagellin gene typing of Campylobacter jejuni by restriction fragment length polymorphism analysis. J Clin Microbiol1993 ; 31: 1531—1536.
41.
Nachamkin I., Ung H., Patton CMAnalysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system. J Clin Microbiol1996; 34: 277—281.
42.
Owen RJ, Leeton S.Restriction fragment length polymorphism analysis of the flaA gene of Campylobacter jejuni for subtyping human, animal and poultry isolates. FEMS Microbiol Lett1999; 176: 345—350.
43.
Patton CM, Nicholson MA, Ostroff SM, Ries AA, Wachsmuth IK, Tauxe RVCommon somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States. J Clin Microbiol1993; 31: 1525—1530.
44.
Cardarelli-Leite P., Blom K., Patton CM et al. Rapid identification of Campylobacter species by restriction fragment length polymorphism analysis of a PCR-amplified fragment of the gene coding for 16S rRNA. J Clin Microbiol1996; 34: 62—67.
45.
Ragimbeau C. , Salvat G., Colin P., Ermel G.Development of a multiplex PCR gene fingerprinting method using gyrA and pflA polymorphisms to identify genotypic relatedness within Campylobacter jejuni species. J Appl Microbiol1998; 85: 829—838.
46.
Szymanski CM , Yao R., Ewing CP, Trust TJ, Guerry P.Evidence for a system of general protein glycosylation in Campylobacter jejuni. Mol Microbiol1999 ; 32: 1022—1030.
47.
Fry BN, Feng S., Chen YY, Newell DG, Coloe PJ, Korolik V.The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence. Infect Immun2000; 68: 2594—2601.
48.
Gilbert M., Brisson JR, Karwaski MF et al. Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-MHz 1H and 13C NMR analysis. J Biol Chem2000; 275: 3896—3906.
49.
Guerry P., Ewing CP, Hickey TE, Prendergast MM, Moran APSialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect Immun2000; 68: 6656—6662.
50.
Linton D., Gilbert M., Hitchen PG et al. Phase variation of a β-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni. Mol Microbiol2000; 37: 501—514.
51.
Nishimura M. , Nukina M., Yuan JM et al. PCR-based restriction fragment length polymorphism (RFLP) analysis and serotyping of Campylobacter jejuni isolates from diarrheic patients in China and Japan. FEMS Microbiol Lett1996; 142: 133—138.
52.
Misawa N., Shinohara S., Satoh H. et al. Isolation of Campylobacter species from zoo animals and polymerase chain reaction-based random amplified polymorphism DNA analysis. Vet Microbiol2000; 71: 59—68.
53.
Wassenaar TM , Fry BN, Lastovica AJ, Wagenaar JA, Coloe PJ, Duim B.Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barré Syndrome. J Clin Microbiol2000; 38: 874—876.
54.
Wang L., Curd H., Qu W., Reeves PRSequencing of Escherichia coli O111 O-antigen gene cluster and identification of O111-specific genes. J Clin Microbiol1998 ; 36: 3182—3187.
55.
Louie M., Read S., Simor AE et al. Application of multiplex PCR for detection of non-O157 verocytotoxin-producing Escherichia coli in bloody stools: identification of serogroups O26 and O111 . J Clin Microbiol1998; 36: 3375—3377.
56.
Maurer JJ, Schmidt D., Petrosko P., Sanchez S., Bolton L., Lee MDDevelopment of primers to O-antigen biosynthesis genes for specific detection of Escherichia coli O157 by PCR. Appl Environ Microbiol1999; 65: 2945—2960.
57.
Paton AW, Paton JCDirect detection of Shiga toxigenic Escherichia coli strains belonging to serogroups O111, O157, and O113 by multiplex PCR. J Clin Microbiol1999; 37: 3362—3365.
